Improvement Of Immunisupressive Therapie After Kidney Allotransplantation
Abstract
The results of kidney transplantation in two groups of recipients have been analyzed. The first group: 16 patients were held on the 3-drugs regimen of immunosupression characterized by the high dosage of Cyclosporin A; the second group: 15 patients on the 4-drugs regimen.The fourth component was Bromergon, the prolactin inhibitor. In the second group the dosage of Cy A was three times less (4 mg/ kg/d instead of 12 mg/kg/d). The efficacy of the two said regimens was analyzed using a series of standart clinical and lab parameters and the markers of the transplant rejection: the Tumor Necrosis Factor-alpha (TNF-alpha) and factor VIII of coagulation (Willebrand’s factor). The comparison has shown both clinical and economic effect of the 4-drug regimen of immunosupression.
References
1. Hardy J., Beauregard H. and Robert F. In progress in Prolactin Physiology and Pathology. Elsevier North Holland, New York. 1978; 361-370.
2. Nady E. and Berczi I. Acta Endocrinology 89, 1978; 530-537, 102, 351-357.
3. Novonha T.L., Daniel V. et al. Transplantation Proceedings 1990; vol. 22, 4, 1859-1860.
4. Vanson W.J., Brijker F. Transplantation Proceedings 1997; 1,2, 161-162.
5. Russell D., Martizian L. Prolactin Receptors on Human Lymphocytes and Their Modulation by Cyclosporin. Biochemical and Biophysical Reseach Communications, 1984; vol. 121, 3, 899-906.
Review
For citations:
Kalatchik O.V. Improvement Of Immunisupressive Therapie After Kidney Allotransplantation. Nephrology and Dialysis. 2000;2(1-2):44-48. (In Russ.)
Views:
7
Email this article 